Published in JAMA on November 27, 2013
Thalidomide in Pediatric Inflammatory Bowel Diseases. (TALIBDP) | NCT00720538
Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. Inflamm Bowel Dis (2015) 1.09
Use of placebo in a trial of thalidomide for pediatric Crohn disease. JAMA (2014) 1.08
Advances in pediatric pharmacology, therapeutics, and toxicology. Adv Pediatr (2014) 0.96
Phenome-driven disease genetics prediction toward drug discovery. Bioinformatics (2015) 0.91
Management of Crohn's disease. Arch Dis Child (2015) 0.81
Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review. Medicine (Baltimore) (2016) 0.75
Reply to Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug. Inflamm Bowel Dis (2015) 0.75
Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks. J Pediatr Pharmacol Ther (2016) 0.75
[Effectiveness and security of thalidomide for gastrointestinal bleeding and severe Crohn's disease in children]. Z Gastroenterol (2014) 0.75
Thalidomide results in diminished ovarian reserve in reproductive age female IBD patients. Medicine (Baltimore) (2017) 0.75
Effective treatment of gastrointestinal bleeding with thalidomide - Chances and limitations. World J Gastroenterol (2016) 0.75
Thalidomide for inflammatory bowel disease: Systematic review. Medicine (Baltimore) (2016) 0.75
Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study. Therap Adv Gastroenterol (2017) 0.75
Use of placebo in a trial of thalidomide for pediatric Crohn disease--reply. JAMA (2014) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A (2010) 15.22
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity (2007) 4.87
Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med (2014) 4.64
Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics (2008) 4.20
Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol (2007) 4.16
Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet (2009) 3.19
Burden of disease caused by otitis media: systematic review and global estimates. PLoS One (2012) 2.42
Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med (2014) 2.39
Is intestinal biopsy always needed for diagnosis of celiac disease? Am J Gastroenterol (2003) 2.23
Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol (2008) 2.18
Esophageal impedance in children: symptom-based results. J Pediatr (2010) 2.07
Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia. Dig Dis Sci (2011) 2.02
Celiac disease with mild enteropathy is not mild disease. Clin Gastroenterol Hepatol (2012) 1.90
Extra-large letter spacing improves reading in dyslexia. Proc Natl Acad Sci U S A (2012) 1.82
ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr (2014) 1.78
Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am J Gastroenterol (2005) 1.77
Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J Infect Dis (2002) 1.68
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet (2012) 1.66
Genotype-phenotype correlation in Italian children with Wilson's disease. J Hepatol (2008) 1.63
High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis (2011) 1.54
Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology (2008) 1.52
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J Pediatr Gastroenterol Nutr (2012) 1.52
The pathology of gastric cardia: a prospective, endoscopic, and morphologic study. Am J Surg Pathol (2007) 1.48
Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients. Dig Liver Dis (2013) 1.43
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis. Rheumatol Int (2014) 1.41
Histopathological findings in the oral mucosa of celiac patients. Rev Esp Enferm Dig (2014) 1.39
Use of Placebo in Pediatric Inflammatory Bowel Diseases: A Position Paper From ESPGHAN, ECCO, PIBDnet, and the Canadian Children IBD Network. J Pediatr Gastroenterol Nutr (2016) 1.39
Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol (2007) 1.38
VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr (2010) 1.29
Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res (Hoboken) (2011) 1.24
Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res (2008) 1.21
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr (2007) 1.16
How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. Am J Gastroenterol (2010) 1.15
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays. Am J Gastroenterol (2006) 1.14
The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol (2012) 1.14
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res (2008) 1.14
Semen preparation methods and sperm apoptosis: swim-up versus gradient-density centrifugation technique. Fertil Steril (2008) 1.13
Observations on the paper of Carroccio et al. "non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity". Am J Gastroenterol (2013) 1.13
Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol (2003) 1.12
Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol (2005) 1.10
Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin Gastroenterol Hepatol (2008) 1.09
Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax (2011) 1.09
Assessing mucosal healing in ulcerative colitis: the simpler, the better…. Endoscopy (2015) 1.08
The pathophysiology of chagasic megacolon: beyond ICC…. Virchows Arch (2012) 1.08
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut (2011) 1.07
The enteric nervous system in chagasic and idiopathic megacolon. Am J Surg Pathol (2007) 1.07
Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol (2006) 1.07
Deep sedation with propofol by nonanesthesiologists: a prospective pediatric experience. Arch Pediatr Adolesc Med (2003) 1.07
IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med Genet (2009) 1.06
Stop considering atopic dermatitis as an allergic disease. J Pediatr Gastroenterol Nutr (2013) 1.06
Constipation, anthranoid laxatives, melanosis coli, and colon cancer: a risk assessment using aberrant crypt foci. Cancer Epidemiol Biomarkers Prev (2002) 1.06
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics (2009) 1.05
Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis (2013) 1.05
Family history in early-onset inflammatory bowel disease. J Gastroenterol (2012) 1.04
Serum transaminases in children with Wilson's disease. J Pediatr Gastroenterol Nutr (2004) 1.04
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments. Eur J Biochem (2002) 1.03
Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr (2006) 1.03
Biliary cystadenoma with bile duct communication depicted on liver-specific contrast agent-enhanced MRI in a child. Pediatr Radiol (2010) 1.03
SpyGlass single-operator peroral cholangioscopy in the evaluation of indeterminate biliary lesions: a single-center, prospective, cohort study. Surg Endosc (2012) 1.02
Anti transglutaminase antibodies cause ataxia in mice. PLoS One (2010) 1.02
Dilated intercellular spaces: a major morphological feature of esophagitis. J Pediatr Gastroenterol Nutr (2006) 1.02
Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol (2011) 1.01
Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology (2015) 1.01
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. Eur Heart J (2003) 1.01
Is it possible to improve the histological yield of oesophageal endoscopic mucosectomies? Dig Liver Dis (2011) 1.00
Primary Extra-gastrointestinal Stromal Tumor of Retroperitoneum. Clin Med Insights Oncol (2012) 1.00
Stress response and procedural pain in the preterm newborn: the role of pharmacological and non-pharmacological treatments. Eur J Pediatr (2011) 1.00
Leigh Syndrome with COX deficiency and SURF1 gene mutations: MR imaging findings. AJNR Am J Neuroradiol (2003) 1.00
A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr (2009) 0.99
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol (2008) 0.99
Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr (2014) 0.99
Hemolytic effects of water-soluble fullerene derivatives. J Med Chem (2004) 0.98
Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations. J Pediatr Gastroenterol Nutr (2011) 0.98
Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J Pineal Res (2011) 0.97
A new mutation in two siblings with cystinosis presenting with Bartter syndrome. Pediatr Nephrol (2004) 0.97
Hospitalizations after a decade of pneumococcal vaccination. N Engl J Med (2013) 0.97
Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Pediatrics (2007) 0.96
Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin Immunol (2011) 0.96